A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide
Manabu Kaneko(Tokyo University of Science), Takaji Wakita(National Institute of Infectious Diseases), Hideki Aizaki(National Institute of Infectious Diseases), Sam‐Yong Park(Yokohama City University Medical Center), Fumio Sugawara(Tokyo University of Science), Takayoshi Ito(SHOWA Medical University), Senko Tsukuda(National Institute of Infectious Diseases), Masaya Sugiyama(National Center for Global Health and Medicine), Naoko Ohtani(Osaka Metropolitan University), Camille Sureau(Génomes, biologie cellulaire et thérapeutiques), Masashi Iwamoto(Rockefeller University), Fumihiro Kawai(Yokohama City University), Koichi Watashi(Tokyo University of Science), Hirofumi Ohashi(National Institute of Infectious Diseases), Ryosuke Suzuki(National Institute of Infectious Diseases), Satomi Shimura(National Institute of Infectious Diseases), Masashi Mizokami(National Institute of Advanced Industrial Science and Technology), Yasuhito Tanaka(Kumamoto University), Hiroki Matsunaga(Tokyo University of Science), Shinji Kamisuki(Tokyo University of Science)
Cited by 97
Related Papers
An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
|Developmental Cell|2014|2k
Consensus Proposals for a Unified System of Nomenclature of Hepatitis C Virus Genotypes *
|Hepatology|2005|1.5k
A proposed system for the nomenclature of hepatitis C viral genotypes
|Hepatology|1994|1k